Gilead Sciences (GILD)

Capital Expenditure

$117.00M

Quarterly · Period ending: · USD

GILD logo

GILD Capital Expenditure

Latest reported$117.00M
GILD Quarterly CapEx (-$300.00K → $117.00M)
High-resolution chart · PNG

GILD capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
117,000,000
-117,000,000
-205,000,000
-147,000,000
-107,000,000
-104,000,000
-147,000,000
-141,000,000
-130,000,000
-105,000,000
-215,000,000
-122,000,000
-139,000,000
-109,000,000
-181,000,000
-157,000,000
-143,000,000
-247,000,000
-156,000,000
-139,000,000
-119,000,000
-165,000,000
-181,000,000
-155,000,000
-143,000,000
-171,000,000
-203,000,000
-200,000,000
-185,000,000
-237,000,000
-248,000,000
-167,000,000
-297,000,000
-212,000,000
-220,000,000
-129,000,000
-123,000,000
-118,000,000
-169,000,000
-198,000,000
-204,000,000
-177,000,000
-166,000,000
-286,000,000
-171,000,000
-124,000,000
-167,451,000
-135,000,000
-91,000,000
-164,000,000
-69,472,000
-37,180,000
-45,276,000
-38,854,000
-269,871,000
-66,584,000
-37,392,000
-23,199,000
-26,110,000
-64,289,000
-26,635,000
-14,870,000
-23,361,000
-10,806,000
-16,051,000
-11,666,000
-26,987,000
-18,125,000
-20,874,000
-164,071,000
-41,660,000
-31,398,000
-25,198,000
-16,749,000
-19,322,000
-12,496,000
-21,789,000
-25,041,000
-30,213,000
-41,411,000
-19,326,000
-14,258,000
-13,042,000
-11,286,000
-14,748,000
-8,875,000
-22,270,000
-10,899,000
-12,842,000
-5,355,000
0
-115,187,000
-5,143,000
-2,670,000
-5,075,000
-4,251,000
-5,241,000
-3,030,000
-9,670,000
-5,622,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.